Recombinant Antibodies

Recombinant Antibodies – Anti-PD1, Anti-PDL1, Anti-CTLA4, and More

Our high-quality recombinant antibodies are designed for advanced immunological research, including cancer immunotherapy studies, checkpoint inhibition assays, and immune profiling. Available targets include PD1, PDL1, CTLA4, and other key immune regulators. These antibodies offer:

• High specificity & affinity: Ensures precise targeting with minimal off-target effects.

• Reproducibility: Recombinant production guarantees consistent performance across experiments.

• Versatility: Suitable for flow cytometry, Western blotting, ELISA, immunohistochemistry, and functional assays.

• Validated quality: Each antibody is rigorously tested for performance in relevant applications.

Ideal for: Immuno-oncology research, checkpoint blockade studies, and preclinical drug development.